1048 related articles for article (PubMed ID: 33275517)
21. Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.
Imani-Saber Z; Vaseghi H; Mahdian M; Safari F; Ghadami M
Iran J Allergy Asthma Immunol; 2020 Oct; 19(5):456-470. PubMed ID: 33463113
[TBL] [Abstract][Full Text] [Related]
22. Androgens, the kidney, and COVID-19: an opportunity for translational research.
Yanes Cardozo LL; Rezq S; Pruett JE; Romero DG
Am J Physiol Renal Physiol; 2021 Feb; 320(2):F243-F248. PubMed ID: 33464168
[TBL] [Abstract][Full Text] [Related]
23. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
Hrenak J; Simko F
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
[TBL] [Abstract][Full Text] [Related]
24. Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19.
García-Escobar A; Vera-Vera S; Jurado-Román A; Jiménez-Valero S; Galeote G; Moreno R
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053224
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein.
Khaddaj-Mallat R; Aldib N; Bernard M; Paquette AS; Ferreira A; Lecordier S; Saghatelyan A; Flamand L; ElAli A
Neurobiol Dis; 2021 Dec; 161():105561. PubMed ID: 34780863
[TBL] [Abstract][Full Text] [Related]
26. Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus?
Majdic G
Front Cell Infect Microbiol; 2020; 10():327. PubMed ID: 32582576
[TBL] [Abstract][Full Text] [Related]
27. Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19.
Pedrosa MA; Valenzuela R; Garrido-Gil P; Labandeira CM; Navarro G; Franco R; Labandeira-Garcia JL; Rodriguez-Perez AI
Clin Sci (Lond); 2021 Feb; 135(3):465-481. PubMed ID: 33479758
[TBL] [Abstract][Full Text] [Related]
28. Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients.
Rahman MM; Hasan M; Ahmed A
Rev Med Virol; 2021 Sep; 31(5):1-12. PubMed ID: 33426683
[TBL] [Abstract][Full Text] [Related]
29. Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling.
Keewan E; Beg S; Naser SA
Front Immunol; 2021; 12():641295. PubMed ID: 34025650
[TBL] [Abstract][Full Text] [Related]
30. [Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the
Zuraeva ZT; Vikulova OK; Malysheva NM; Nikankina LV; Zaytceva NV; Sukhareva OY; Shamhalova MS; Shestakova MV; Mokrysheva NG
Probl Endokrinol (Mosk); 2023 Aug; 69(4):21-31. PubMed ID: 37694864
[TBL] [Abstract][Full Text] [Related]
31. Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility.
Azinheira Nobrega Cruz N; Stoll D; Casarini DE; Bertagnolli M
Clin Sci (Lond); 2021 Aug; 135(15):1805-1824. PubMed ID: 34338772
[TBL] [Abstract][Full Text] [Related]
32. Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2).
Wiese O; Zemlin AE; Pillay TS
J Clin Pathol; 2021 May; 74(5):285-290. PubMed ID: 32759311
[TBL] [Abstract][Full Text] [Related]
33. ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders.
Cao X; Song LN; Yang JK
Clin Sci (Lond); 2021 Feb; 135(3):535-554. PubMed ID: 33533405
[TBL] [Abstract][Full Text] [Related]
34. Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome.
Foresta C; Rocca MS; Di Nisio A
J Endocrinol Invest; 2021 May; 44(5):951-956. PubMed ID: 32936429
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.
Saba L; Gerosa C; Fanni D; Marongiu F; La Nasa G; Caocci G; Barcellona D; Balestrieri A; Coghe F; Orru G; Coni P; Piras M; Ledda F; Suri JS; Ronchi A; D'Andrea F; Cau R; Castagnola M; Faa G
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12609-12622. PubMed ID: 33336781
[TBL] [Abstract][Full Text] [Related]
36. Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry.
Ragia G; Manolopoulos VG
Pharmacogenomics; 2020 Dec; 21(18):1311-1329. PubMed ID: 33243086
[TBL] [Abstract][Full Text] [Related]
37. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
38. Sex hormones and COVID-19: tussle between the two.
Patil A; Tripathy JP; Deshmukh V; Sontakke B; Tripathi SC
Monaldi Arch Chest Dis; 2020 Sep; 90(4):. PubMed ID: 32945643
[TBL] [Abstract][Full Text] [Related]
39. Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression.
Konwar C; Asiimwe R; Inkster AM; Merrill SM; Negri GL; Aristizabal MJ; Rider CF; MacIsaac JL; Carlsten C; Kobor MS
Epigenetics Chromatin; 2021 Dec; 14(1):54. PubMed ID: 34895312
[TBL] [Abstract][Full Text] [Related]
40. Sex-based differences in severity and mortality in COVID-19.
Alwani M; Yassin A; Al-Zoubi RM; Aboumarzouk OM; Nettleship J; Kelly D; Al-Qudimat AR; Shabsigh R
Rev Med Virol; 2021 Nov; 31(6):e2223. PubMed ID: 33646622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
